Information updates

Autoinflammatory Disease Symposium

The 2nd Australian Autoinflammatory Disease Symposium is being hosted by the Walter and Eliza Hall Institute (WEHI) on Monday 29 August 2022, prior to the ASCIA 2022 Conference in Melbourne.

This symposium will facilitate discussion of autoinflammatory diseases, spanning research, clinical management and a session for patients and their support networks.

This hybrid event can be attended in-person or viewed online and a registration fee of $50.00 applies for in-person attendees and includes morning tea, lunch, afternoon tea and post event refreshments. Registration is free for students and virtual attendees.

Registrations close 5pm (AEST) Monday 8 August 2022 for in person and online attendees. 

To register go to

If you are feeling unwell on the day, please do not attend this event in person, instead view online. WEHI recommends wearing a mask while visiting the institute where social distancing is not possible.

Further details are shown below. 

For event enquiries, please email This email address is being protected from spambots. You need JavaScript enabled to view it.


Science session: The molecular basis of autoinflammation

9:00am -10.30am

  • Kate Schroder (UQ, Science overview, NLRP3 inhibitor update)
  • Najoua Laloui (PeterMac, AID due to cleavage resistant RIPK1)
  • Ivona Aksentijevich (NIH, Ubiquitination and Autoinflammation)
  • Marcia Munoz (Garvan, Prenylation in Mevalonate Kinase Deficiency)

11:00am - 12.30pm

  • Shane Grey (Garvan, Haploinsufficiency of A20)
  • Sophia Davidson (WEHI, Dominant negative Otulin deficiency)
  • Elisabeth Mulazzani (WEHI, Blockade of G-CSF for APLAID)
  • 2 x short talks from abstracts

Clinical session: Treatment and therapy of AID

1.30pm - 3:00pm

  • Ed Giles (Monash, Advances in diagnosis and therapy of EOIBD)
  • Rohit Saldanha (SCH, JAK inhibition for interferonopathies)
  • Samar Ojaimi (Monash) and Thomas Reygaerts (WEHI, CDC42 AID)

3.30pm - 5:00pm

  • Peter McNaughton (QCH, diagnosis of AID)
  • Jonathan Akikusa (RCH, targeting biological therapy for AID)
  • Marco Gattorno (Italy, AID diagnosis and therapy overview)
  • Karen Raymond (Adelaide, Personal take on life with, and research of, AID)

Patient Session: Panel Discussion

5:00pm - 6:00pm

  • Nicole Millis (RareVoices Australia)
  • Marco Gattorno (Italy, Pediatric Rheumatology)
  • Melanie Wong (Westmead, Pediatric Immunology)
  • Jeff Chaitow (SCH, Pediatric Rheumatology)
  • Charlotte Slade (Melb Health, Clinical Immunology)
  • Michael O’Sullivan (FSH, Clinical Immunology)
Abstract Submission

Two talks will be selected from abstracts. Please submit a single page word doc or pdf to be included in the symposium handbook. Include a photo (headshot) of the presenter so that delegates can engage with questions during breaks

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Submission deadline is 29 July 2022.

Organising committee
  • Seth Masters (WEHI)
  • Mike Rogers (Garvan)
  • Samar Ojami (Monash)
  • Sam Mehr (RCH)
  • Marcia Munoz (Garvan)

This news item was issued on 5 June 2022 by Jill Smith, CEO of the Australasian Society of Clinical Immunology and Allergy (ASCIA). ASCIA is the peak professional body for clinical immunology and allergy in Australia and New Zealand.   

Mod ASCIA Member
Donate to AIFA
go to NAC website

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia